A. Aghazadeh‐Habashi

发表

Targeting the Protective Arm of the Renin-Angiotensin System: Focused on Angiotensin-(1–7)

A. Aghazadeh-Habashi, Sana Khajehpour, A. Aghazadeh‐Habashi, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Absorption and bioavailability of glucosamine in the rat.

F. Jamali, A. Aghazadeh-Habashi, Alyaa Ibrahim, 2012, Journal of pharmaceutical sciences.

Single dose pharmacokinetics and bioavailability of glucosamine in the rat.

F. Jamali, A. Aghazadeh-Habashi, S. Sattari, 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Transdermal drug delivery: feasibility for treatment of superficial bone stress fractures

M. Doschak, A. Aghazadeh-Habashi, Yang Yang, 2015, Drug Delivery and Translational Research.

Renin–Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19

E. Middleton, Robert Campbell, Sana Khajeh pour, 2023, Biomedicines.

Update on Angiotensin II Subtype 2 Receptor: Focus on Peptide and Nonpeptide Agonists

A. Aghazadeh-Habashi, Sana Khajehpour, Arina Ranjit, 2021, Molecular Pharmacology.

Single dose pharmacokinetics and bioavailability of glucosamine in the rat.

Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis

A. Aghazadeh-Habashi, Arina Ranjit, Sana Khajeh Pour, 2022, Pharmaceutics.

Anti-Inflammatory Effects of Ang-(1-7) Bone-Targeting Conjugate in an Adjuvant-Induced Arthritis Rat Model

A. Aghazadeh-Habashi, Arina Ranjit, Sana Khajeh Pour, 2022, Pharmaceuticals.

Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid.

F. Jamali, A. Aghazadeh-Habashi, Waheed Asghar, 2018, Journal of pharmaceutical sciences.

Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis

F. Jamali, A. Aghazadeh-Habashi, Waheed Asghar, 2017, Inflammopharmacology.

Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations.

F. Jamali, A. Aghazadeh-Habashi, A. Aghazadeh‐Habashi, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Rapidly dissolving formulations for quick absorption during pain episodes: ibuprofen.

F. Jamali, A. Aghazadeh-Habashi, A. Aghazadeh‐Habashi, 2008, International journal of clinical pharmacology and therapeutics.

Circadian Modulation of the Antioxidant Effect of Grape Consumption: A Randomized Controlled Trial

C. Blanton, A. Aghazadeh-Habashi, Sana Khajeh Pour, 2023, International journal of environmental research and public health.

Active ingredient consistency of commercially available glucosamine sulfate products.

F. Jamali, A. Russell, A. Aghazadeh-Habashi, 2002, The Journal of rheumatology.

Improved pharmacokinetics and bone tissue accumulation of Angiotensin-(1–7) peptide through bisphosphonate conjugation

A. Aghazadeh-Habashi, Sana Khajehpour, A. Aghazadeh‐Habashi, 2021, Amino Acids.

The glucosamine controversy; a pharmacokinetic issue.

F. Jamali, A. Aghazadeh-Habashi, A. Aghazadeh‐Habashi, 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Evaluation of glucosamine levels in commercial equine oral supplements for joints.

F. Jamali, J. Weese, A. Aghazadeh-Habashi, 2010, Equine veterinary journal.

EXTENT OF RENAL EFFECT OF CYCLO‐OXYGENASE‐2‐SELECTIVE INHIBITORS IS PHARMACOKINETIC DEPENDENT

F. Jamali, A. Aghazadeh-Habashi, S. Harirforoosh, 2006, Clinical and experimental pharmacology & physiology.

Tissue Engineering Through 3D Bioprinting to Recreate and Study Bone Disease

M. Kirkham, Jared J. Barrott, A. Aghazadeh-Habashi, 2021, Biomedicines.

Disease specific modeling: Simulation of the pharmacokinetics of meloxicam and ibuprofen in disease state vs. healthy conditions.

Raimar Löbenberg, May Almukainzi, R. Löbenberg, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.